Case Reports

Clinical and Radiological Follow-Up of a Pfizer- BioNTech COVID-19 Vaccine-Induced Hemichorea-Hemiballismus

Authors:

Abstract

Background: Hemichorea-hemiballismus is a rare hyperkinetic movement disorder.

Case Report: A 90-year-old male developed left hemichorea-hemiballismus after his second dose of the Pfizer-BioNTech COVID-19 vaccine. A wide range of investigations including magnetic resonance imaging did not reveal an alternative cause. [18F]-fluorodeoxyglucose-positron emission tomography (FDG-PET) showed increases in right putamen fixation compared to the left side. The patient showed significant improvement after five days of intravenous corticosteroids, with a normal FDG-PET.

Discussion: This hemichorea-hemiballismus case shows dynamic restoration of putamen metabolism mirroring clinical evolution after administration of corticosteroids, suggesting an autoimmune COVID-19 vaccine-induced reaction.

Keywords:

HemichoreahemiballismusvaccineFDG-TEPCOVID-19
  • Year: 2022
  • Volume: 12
  • Page/Article: 16
  • DOI: 10.5334/tohm.688
  • Submitted on 1 Feb 2022
  • Accepted on 14 Apr 2022
  • Published on 18 May 2022
  • Peer Reviewed